Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and safety of envafolimab plus lenvatinib combined with TACE in unresectable hepatocellular carcinoma: An open-label, single-arm, phase 2 study—The CISLD-12 study.
PaperCitations, authors & open-access status
Efficacy and safety of envafolimab plus lenvatinib combined with TACE in unresectable hepatocellular carcinoma: An open-label, single-arm, phase 2 study—The CISLD-12 study. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 3 citations, 2023 year and closed oa status.
3
Citations
2023
Year
closed
OA Status